{"id":987174,"date":"2026-07-30T07:40:06","date_gmt":"2026-07-30T11:40:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bacterial-vaginosis-linked-to-increased-sti-co-infection-finds-national-study-of-1-5-million-women-from-quest-diagnostics\/"},"modified":"2026-07-30T07:40:06","modified_gmt":"2026-07-30T11:40:06","slug":"bacterial-vaginosis-linked-to-increased-sti-co-infection-finds-national-study-of-1-5-million-women-from-quest-diagnostics","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bacterial-vaginosis-linked-to-increased-sti-co-infection-finds-national-study-of-1-5-million-women-from-quest-diagnostics\/","title":{"rendered":"Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

Largest nationally representative study finds 12% of patients positive for bacterial vaginosis are infected with at least one STI, such as chlamydia or gonorrhea<\/p>\n

\n SECAUCUS, N.J.<\/span>, July 30, 2026<\/span> \/PRNewswire\/ —\u00a0Women who test positive for bacterial vaginosis (BV) were over three times more likely to also test positive for one or more non-viral sexually transmitted infections (STIs) than women who test negative for BV, according to a new Health Trends\u00ae study<\/a>\u00a0from Quest Diagnostics (NYSE: DGX) and Hologic, Inc.<\/p>\n

\n

\n \"questhealth.com\n <\/p>\n<\/p><\/div>\n

In the largest national study of its kind, scientists at Quest and Hologic analyzed deidentified aggregated laboratory data from over 1.5 million women across the United States who received molecular testing from Quest between 2022 and 2024. Over one-third of women tested (38.7%) were positive for BV. Of these, 12% were co-infected with at least one STI. The findings were published in O&G Open<\/i>, a peer-reviewed companion journal to Obstetrics & Gynecology<\/i>, the official publication of the American College of Obstetricians and Gynecologists (ACOG).<\/p>\n

“BV is one of the most common health problems in women, and yet research in this area of women’s healthcare is sadly lacking. Our new analysis provides compelling evidence that women with BV are at significant risk for STIs based on a uniquely large dataset reflecting the nation’s heterogenous population,” said co-author Damian P. Alagia III, MD, a board-certified obstetrician\/gynecologist and Senior Medical Director, Women’s Health, Quest Diagnostics. “STIs can lead to serious reproductive and other health complications when left undetected and untreated. We hope our new data inspires much-needed additional research on this clinical area while also reinforcing for clinicians and policy makers the value of a comprehensive diagnostic approach that considers STI testing for patients with BV.”<\/p>\n

Growing evidence suggests that changes in the vaginal microbiome may contribute not only to vaginitis, a common condition associated with inflammation, discomfort and infection, but also to increased susceptibility to other STIs, including HIV, chlamydia,<\/i>\u00a0gonorrhea\u00a0and trichomonas.<\/p>\n

Key findings:<\/p>\n